Atlas Trials

Study of Tocilizumab in Combination With Methotrexate for Treatment of Moderate to Severe Rheumatoid Arthritis Patients

Clinical trial NCT01258712 · COMPLETED

Trial details

NCT number
NCT01258712
Sponsor
Chugai Pharma Taiwan
Status
COMPLETED
Phase
Phase 3
Study type
INTERVENTIONAL
Rheumatoid Arthritis (RA)
Start date
2010-12-01
Primary completion
2012-10-01
Enrollment
86

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.